Burns James William Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$1.66M

Insider Activity of Burns James William

According to the SEC Form 4 filings, Burns James William, being in a position of

  1. Chief Legal Officer at Agios Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 11430 shares for $344,390,
    over all time since 2023-06-30, has bought 0 shares, and sold 54146 shares for $2.1M.

Biography of Burns James William

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$344,3903100

Comparison of Insiders on Amount of Buys and Sells

2026-04-02SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Legal Officer
3,280
0.0057%
$34.71$113,849-6.01%
2026-03-02SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Legal Officer
5,218
0.0085%
$28.96$151,113+11.95%
2025-12-30SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Legal Officer
2,932
0.005%
$27.09$79,428+13.04%
2025-06-24SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Legal Officer
2,799
0.0049%
$33.54$93,878-9.55%
2025-03-03SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Legal Officer
4,005
0.0075%
$35.54$142,338-2.99%
2024-11-07SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Legal Officer
21,752
0.0844%
$52.21$1.14M-35.94%
2024-03-05SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Legal Officer
2,642
0.0064%
$32.57$86,050+33.98%
2024-02-14SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Legal Officer
545
0.001%
$25.14$13,701+62.24%
2024-01-24SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Legal Officer
1,708
0.0027%
$21.64$36,961+95.35%
2024-01-09SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Legal Officer
1,163
0.002%
$22.99$26,737+75.08%
2023-08-17SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Legal Officer
6,395
0.0116%
$26.28$168,061+5.01%
2023-06-30SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Legal Officer
1,707
0.0031%
$28.36$48,411-5.99%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.